Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 17;70:111.
doi: 10.1016/j.sleep.2020.04.006. Online ahead of print.

Delirium and Sleep Disturbances in COVID-19: A Possible Role for Melatonin in Hospitalized Patients?

Affiliations
Free PMC article

Delirium and Sleep Disturbances in COVID-19: A Possible Role for Melatonin in Hospitalized Patients?

Elena Zambrelli et al. Sleep Med. .
Free PMC article

Conflict of interest statement

None declared.

The ICMJE Uniform Disclosure Form for Potential Conflicts of Interest associated with this article can be viewed by clicking on the following link: https://doi.org/10.1016/j.sleep.2020.04.006.

Similar articles

See all similar articles

References

    1. Mao L., Jin H., Wang M. Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020 doi: 10.1001/jamaneurol.2020.1127. Published online April 10. - DOI - PMC - PubMed
    1. Salluh J.I., Wang H., Schneider E.B. Outcome of delirium in critically ill patients: systematic review and meta-analysis. BMJ. 2015 Jun 03;350:h2538. - PMC - PubMed
    1. Zhang Q., Gao F., Zhang S. Prophylactic use of exogenous melatonin and melatonin receptor agonists to improve sleep and delirium in the intensive care units: a systematic review and meta-analysis of randomized controlled trials. Sleep Breath. 2019;23(4):1059–1070. doi: 10.1007/s11325-019-01831-5. - DOI - PubMed
    1. Wu G.C., Peng C.K., Liao W.I. Melatonin receptor agonist protects against acute lung injury induced by ventilator through up-regulation of IL-10 production. Respir Res. 2020;21(1):65. doi: 10.1186/s12931-020-1325-2. - DOI - PMC - PubMed
    1. Zhang R., Wang X., Ni L. COVID-19: melatonin as a potential adjuvant treatment. Life Sci. 2020;250:117583. doi: 10.1016/j.lfs.2020.117583. [Epub ahead of print] - DOI - PMC - PubMed
Feedback